Glenmark Pharmaceuticals Limited — Proguanil Exporter Profile
Indian Pharmaceutical Exporter · #2 for Proguanil · $993.6K export value · DGFT Verified
Glenmark Pharmaceuticals Limited is the #2 Indian exporter of Proguanil with $993.6K in export value and 31 verified shipments. Glenmark Pharmaceuticals Limited holds a 0.1% market share in Proguanil exports across 6 countries. The company exports 28 pharmaceutical products worth $205.5M across 14 therapeutic categories.
Glenmark Pharmaceuticals Limited — Proguanil Export Profile: Buyers & Destinations
Where Does Glenmark Pharmaceuticals Limited Export Proguanil?
| Country | Value | Shipments | Share |
|---|---|---|---|
| GERMANY | $574.0K | 16 | 71.3% |
| UNITED ARAB EMIRATES | $100.1K | 5 | 12.4% |
| CANADA | $50.0K | 1 | 6.2% |
| NETHERLANDS | $47.5K | 1 | 5.9% |
| UNITED KINGDOM | $32.8K | 1 | 4.1% |
| ROMANIA | $731 | 8 | 0.1% |
Glenmark Pharmaceuticals Limited exports Proguanil to 6 countries. The largest destination is GERMANY accounting for 71.3% of Glenmark Pharmaceuticals Limited's Proguanil shipments, followed by UNITED ARAB EMIRATES (12.4%) and CANADA (6.2%). These destinations reflect Glenmark Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Proguanil from Glenmark Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| CENTRAFARM SERVICES (ALLOGA NL) B.V | GERMANY | $436.4K | 10 |
| ALIUD PHARMA | GERMANY | $136.9K | 3 |
| GULF DRUG LLC | UNITED ARAB EMIRATES | $100.1K | 5 |
| GLENMARK PHARMACEUTICALS CANADA INC | CANADA | $50.0K | 1 |
| CENTRAFARM SERVICES ALLOGA NL B V | NETHERLANDS | $47.5K | 1 |
| GLENMARK PHARMACEUTICALS EUROPE LTD | UNITED KINGDOM | $32.8K | 1 |
| STADA ARZNEIMITTEL AG | GERMANY | $753 | 3 |
| STADA HEMOFARM SRL | ROMANIA | $731 | 8 |
Glenmark Pharmaceuticals Limited supplies Proguanil to 8 buyers globally. The largest buyer is CENTRAFARM SERVICES (ALLOGA NL) B.V (GERMANY), followed by ALIUD PHARMA (GERMANY) and GULF DRUG LLC (UNITED ARAB EMIRATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Proguanil Export Value and How Much Does Glenmark Pharmaceuticals Limited Contribute?
India exported $4.4M worth of Proguanil through 382 shipments from 38 suppliers to 41 countries, serving 197 buyers globally. Glenmark Pharmaceuticals Limited contributes $993.6K to this total, accounting for 0.1% of India's Proguanil exports. Glenmark Pharmaceuticals Limited ships Proguanil to 6 countries through 8 buyers.
What Is the Average Shipment Value for Glenmark Pharmaceuticals Limited's Proguanil Exports?
Glenmark Pharmaceuticals Limited's average Proguanil shipment value is $32.1K per consignment, based on 31 shipments totaling $993.6K. The largest destination is GERMANY (71.3% of Glenmark Pharmaceuticals Limited's Proguanil exports).
How Does Glenmark Pharmaceuticals Limited Compare to Other Indian Proguanil Exporters?
Glenmark Pharmaceuticals Limited ranks #2 among 38 Indian Proguanil exporters with a 0.1% market share. The top 3 exporters are MYLAN LABORATORIES LIMITED ($2.4M), GLENMARK PHARMACEUTICALS LIMITED ($993.6K), HETERO LABS LIMITED ($378.4K). Glenmark Pharmaceuticals Limited processed 31 shipments to 6 destination countries.
What Proguanil Formulations Does Glenmark Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ATOVAQUONE PROGUANIL TAB250/100MG 12'SCFNL SNL231348C632301AZNOS | $129.1K | 3 |
| ATOVAQUONE PROGUANIL TAB250/100MG12'SCFNL SNL231348C632301AZNOS | $107.3K | 3 |
| MALAGLEN TABLETS 1X12'S UAE (MALAGLEN TABLETS 250 MG/100 MG) (GENERIC NAME" ATOVAQUONE & PROGUANIL HYDROCHLORIDE TABLETS | $58.4K | 3 |
| ATOVAQUONE PROGUANIL TAB250/100MG 12' SC | $50.0K | 1 |
| ATOVAQUONEPROGUANIL TAB250/100MG12'SCFN | $50.0K | 1 |
| ATOVAQUONE/PROGUANIL 250/100MG 36S AL DE | $50.0K | 1 |
| ATOVAQUONE PROGUANIL TAB250/100MG 12'S CFNL SNL231348C632301AZNOS | $50.0K | 1 |
| ATOVA & PROG TAB 250/100 MG 12'S CA (Atovaquone and Proguanil Hydrochloride Tablets) (QTY: 14,196 CAR) | $50.0K | 1 |
| ATOVAQUONE PROGUANIL TAB250 /100MG 12S CFNL SNL231348C632301AZ | $50.0K | 1 |
| ATOVAQUONE / PROGUANIL 250/100MG 36S ALDE SDE321678C632303AZ | $50.0K | 1 |
Glenmark Pharmaceuticals Limited exports 22 distinct Proguanil formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ATOVAQUONE PROGUANIL TAB250/100MG 12'SCFNL SNL231348C632301A with 3 shipments worth $129.1K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Proguanil to Key Markets
What Glenmark Pharmaceuticals Limited must comply with to export Proguanil to its top destination countries
Germany — BfArM/EMA
Approval Process
Marketing Authorisation via Decentralized or Mutual Recognition Procedure under EU Directive 2001/83/EC. CTD Module 1–5 dossier required.
Timeline: 12–18 months via Decentralized Procedure
GMP & Export Requirements
EU GMP (EudraLex Vol. 4); GMP certificate from EU competent authority; WHO Prequalification accepted as supporting evidence
Certificate of Pharmaceutical Product (CPP) from CDSCO; Written Confirmation for API export per EU requirements; EU FMD serialization mandatory
Note: Indian manufacturers must hold EU GMP certificate. EU Falsified Medicines Directive (FMD) serialization and tamper-evident packaging mandatory.
Canada — HC
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Glenmark Pharmaceuticals Limited Compare to Nearest Proguanil Exporters?
Exporters ranked immediately above and below #2 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | MYLAN LABORATORIES LIMITED | $2.4M | 47 | 4 | $50.0K |
| 2 | GLENMARK PHARMACEUTICALS LIMITED ★ | $993.6K | 31 | 6 | $32.1K |
| 3 | HETERO LABS LIMITED | $378.4K | 12 | 3 | $31.5K |
| 4 | MANCARE PHARMACEUTICALS PRIVATE LIMITED | $354.1K | 11 | 1 | $32.2K |
Glenmark Pharmaceuticals Limited ranks #2 among 38 Indian Proguanil exporters. Average shipment value of $32.1K compared to the market average of $116.7K. The closest competitors by value are MYLAN LABORATORIES LIMITED and HETERO LABS LIMITED.
Which Indian Ports Ship Proguanil Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 154 | 40.3% |
| SAHAR AIR CARGO ACC (INBOM4) | 100 | 26.2% |
| Bombay Air | 25 | 6.5% |
| JNPT | 21 | 5.5% |
| NHAVA SHEVA SEA (INNSA1) | 20 | 5.2% |
| APIIC PHARMA SEZ | 12 | 3.1% |
| JNPT/ NHAVA SHEVA SEA | 9 | 2.4% |
| Bombay Air Cargo | 9 | 2.4% |
What Other Antimalarial & Antiparasitic Products Does Glenmark Pharmaceuticals Limited Export?
Glenmark Pharmaceuticals Limited also exports these antimalarial & antiparasitic products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Glenmark Pharmaceuticals Limited's Proguanil Exports
Glenmark's export operations are influenced by various geopolitical factors. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, causing increased freight costs and extended transit times. These challenges are particularly impactful for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in logistics and supply chain management. (pharmaceuticalcommerce.com)
Conversely, the US-China trade tensions have opened avenues for Indian pharmaceutical companies like Glenmark to expand their footprint in the US market. The shifting trade dynamics have prompted US importers to seek alternative suppliers, presenting growth opportunities for Indian exporters.
The recent India-European Union Free Trade Agreement (FTA) is poised to benefit Glenmark by eliminating tariffs on pharmaceutical exports to the EU. This development enhances the company's competitiveness in the European market, potentially boosting export volumes and revenue streams. (en.wikipedia.org)
Glenmark Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Glenmark's export success. The company has consistently adhered to guidelines set by the US FDA, WHO, and EU GMP, ensuring the quality and safety of its products. Notably, Glenmark's manufacturing facilities have undergone rigorous inspections, reflecting its commitment to maintaining high-quality standards.
The evolving regulatory landscape, including the EU's Falsified Medicines Directive, necessitates continuous adaptation. Glenmark's proactive approach to compliance positions it well to navigate these changes, thereby sustaining its market access and reputation.
About Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited exports 28 products worth $205.5M. Beyond Proguanil, top products include Rosuvastatin, Omeprazole, Gabapentin, Ondansetron, Naproxen. View the complete Glenmark Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Proguanil — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Proguanil shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Glenmark Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 32 individual customs records matching Glenmark Pharmaceuticals Limited exporting Proguanil, covering 22 formulations to 6 countries via 8 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 41+ countries, 197+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Proguanil Export Data from Glenmark Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Glenmark Pharmaceuticals Limited's Proguanil exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Glenmark Pharmaceuticals Limited
Full Company Profile →
28 products · $205.5M total trade · 14 categories
Proguanil Stats
Company Overview
Top Products by Glenmark Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Glenmark Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Proguanil. For current shipment-level data, contact TransData Nexus.